| 标题 |
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Galina Velikova; James P. Morden; Joanne Haviland; Charlotte Emery; Peter Barrett‐Lee; et al 出版日期:2023-11-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)